Altus Pharmaceuticals Inc.
Altus Pharmaceuticals Announces Closing of $88.5 Million Public Offering
Published in Law and Health Weekly, May 12th, 2007
Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, announced that it has completed the previously announced underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $14.75 per share. The aggregate gross proceeds from the offering were approximately $88.5 million before deducting underwriting discounts and commissions and offering expenses. Altus Pharmaceuticals has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock to cover over-allotments, if any. All of the shares...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP
Calls for Rx Marketing Reform to Lower Cost of Prescription Drugs - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters - Allergies
Allergy & Asthma Network Mothers of Asthmatics Exposes Potentially Dangerous Asthma Medications - Altus Pharmaceuticals
Altus Pharmaceuticals Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock - American Tort Reform Association
Survey Shows Alabamans Expect Transparency, Accountability From Attorney General - Array BioPharma Inc.
Array BioPharma Inc. Announces Proposed Public Offering of Common Stock - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
